Drug sales through retail pharmacies in 13 major markets grew 5% overall at constant exchange rates, or 3% in US$ terms, in the 12 months to May 2006, to total $373.48 billion, reports IMS Health's Retail Drug Monitor. The rate of increase shows no change from recently reported figures for April 2006 (Marketletter June 26), although the downward trend for the current US$ growth figure appears to have reached a trough (Marketletter May 29).
Once again, the fastest-growing market was Brazil, up 41% to $8.033 billion (42% for April), while Mexico and Argentina saw slower growth, at 15% to $7.80 billion and 14% to $2.13 billion, respectively. Overall, the Latin American market's three leading players grew 25%, with no other region showing double-digit rises in the IMS Health study, almost matching previously-reported growth rates of 26%.
USA back to over 50% of IMS markets
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze